Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in New Hampshire: The Definitive Guide for Patients and Families

When you chose to move forward with a breast procedure—whether it was a life-saving reconstruction following a mastectomy at a center like Dartmouth-Hitchcock in Lebanon, a prophylactic surgery due to a BRCA1/BRCA2 mutation, or an aesthetic augmentation in one of the high-volume practices in Manchester or Nashua—you did so with the expectation that the materials placed in your body were proven safe for that specific purpose.

The reality that many women across New Hampshire are now discovering is far more troubling. At The Manginello Law Firm, PLLC, operating under our consumer brand Attorney911, we have spent twenty-seven years advocating for the catastrophically injured. Our managing partner, Ralph Manginello, and associate attorney Lupe Peña have built a practice dedicated to holding massive institutions and manufacturers accountable when they prioritize profits over patient safety. Whether you are navigating the medical complexities of BIA-ALCL, struggling with the systemic inflammation of “Red Breast Syndrome” caused by an acellular dermal matrix (ADM), or facing the failure of a bioabsorbable scaffold like GalaFLEX, we are here to provide the clinical and doctrinal command your case requires.

You may be reading this from a hospital bed at Elliot Hospital, a recovery center in Concord, or your home in the Seacoast region, feeling a mix of pain, betrayal, and confusion. We understand that your journey through breast surgery was likely intended to be a path toward healing or confidence. To find out that your body was used as a testing ground for devices not explicitly cleared for breast surgery is a trauma that demands justice. Our firm, which is currently prosecuting high-profile institutional-liability cases like Bermudez v. Pi Kappa Phi seeking $10,000,000 in damages, has the federal-court experience and the technical rigor to stand against the manufacturers of these defective products.

If you suspect your reconstruction or augmentation is failing, or if you have received a diagnosis of a breast-implant-associated malignancy, please understand that you are not alone in New Hampshire. We invite you to call us at 1-888-ATTY-911 for a confidential, no-obligation consultation. Hablamos español, and Lupe Peña is available to conduct full consultations in Spanish to ensure your family fully understands your legal rights.

The Reality of Medical Device Failure in New Hampshire

New Hampshire possesses a unique medical landscape. We recognize that while many patients receive world-class oncology care in Lebanon at the state’s only NCI-designated Comprehensive Cancer Center, others travel across the border into Boston or seek private aesthetic care in the high-density surgical centers of Hillsborough and Rockingham counties. This geographic spread often means that a woman’s medical records are scattered across different health systems, making it difficult to identify exactly what was implanted during her “internal bra” procedure or reconstruction.

When we look at the cases emerging in the Granite State, we see a pattern of “off-label” promotion. This occurs when a manufacturer markets a device for a use that the FDA has not specifically studied or cleared. In the context of breast surgery, the FDA issued a landmark letter on November 9, 2023, stating clearly that the safety and effectiveness of surgical mesh in breast surgery has not been determined. Yet, for years, devices like GalaFLEX and Pelloss have been used to reinforce tissue in New Hampshire operating rooms.

Understanding the Materials: Mesh, ADM, and Scaffolds

To understand your legal options, we must first look at the science of what was placed in your body. We categorize these devices into three primary groups:

1. Acellular Dermal Matrix (ADM): These are “biologic” meshes derived from human or animal skin (porcine or bovine). Products like AlloDerm (Allergan/AbbVie), Strattice, FlexHD (MTF Biologics), and AlloMax (C.R. Bard/BD) have been used extensively to provide a “pocket” for breast implants. However, the FDA’s March 2021 communication specifically warned that FlexHD and AlloMax showed significantly higher rates of infection and reoperation.
2. Bioabsorbable Scaffolds: These are synthetic materials designed to be absorbed by your body over 12 to 24 months. The most prominent example is GalaFLEX, made by Tepha/Galatea (now part of Becton Dickinson). These scaffolds use a plastic called poly-4-hydroxybutyrate (P4HB). We are seeing cases where these scaffolds do not “dissolve” as promised, leading to palpable edges, chronic pain, and late-stage failure.
3. Synthetic Mesh: While less common in modern breast reconstruction, permanent polypropylene meshes originally designed for hernia repair have been used off-label in the breast, often with catastrophic results including tissue erosion and chronic nerve pain.

If you are experiencing redness, swelling, or a “bottoming out” of your reconstruction, it is vital to secure your operative reports. We can help you navigate the records departments at Southern New Hampshire Health, Portsmouth Regional Hospital, or any other facility to find the “implant stickers” that identify the brand and lot number of these devices.

The Scientific and Pathological Case Against the Manufacturers

Our firm does not merely handle car accidents; we examine the hyper-scientific mechanisms of injury. In breast device litigation, the science is the spine of the case. When we represent a woman in New Hampshire, we look for several specific pathological markers that indicate a manufacturer’s liability.

BIA-ALCL and BIA-SCC: The Oncological Risks

One of the most severe complications we address is Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). This is not breast cancer; it is a CD30-positive, ALK-negative T-cell lymphoma that grows in the scar tissue (capsule) around the implant. While largely associated with textured implants like the Allergan BIOCELL (recalled in July 2019), the use of ADM and scaffolds can complicate the inflammatory environment that leads to this malignancy.

Furthermore, we are monitoring the emerging literature on BIA-SCC (Squamous Cell Carcinoma). In March 2023, the FDA updated its safety communication to report cases where cancer was found in the capsule of both smooth and textured implants. For a woman in New Hampshire who underwent reconstruction a decade ago and is only now feeling a change in her breast shape or a persistent fluid collection (seroma), the need for biopsy and specialized pathology is urgent.

Red Breast Syndrome and Endotoxin Science

Many patients who suffer from persistent redness are told they have a “minor infection.” However, the science of Red Breast Syndrome (RBS) reveals a different cause: endotoxins. Even after “sterilization,” acellular dermal matrices can retain lipopolysaccharides (endotoxins) from the original bacterial cell walls.

Technical research, such as the Nguyen et al. (2019) study, has documented endotoxin levels in ADM grafts that trigger an intense sterile inflammatory response. This is a manufacturing defect. If the product was not properly “washed” of these antigens before being packaged and sold to New Hampshire surgeons, the manufacturer—not your surgeon—may be liable for the weeks of unnecessary antibiotics and the eventual loss of your reconstruction.

The P4HB Hydrolysis Failure

For those with GalaFLEX or Phasix scaffolds, the failure often relates to the “resorption” profile. The manufacturer, Becton Dickinson (BD), claims these products provide a scaffold for your own tissue to grow into before disappearing. However, the whistleblower record of Dr. Hooman Noorchashm, a former BD Medical Director, alleges that the company withheld data regarding complications and breast cancer recurrences in their clinical trials.

If your scaffold has remained palpable three years after surgery, or if you feel sharp, needle-like pain (intercostal neuralgia) where the mesh was tacked to your ribs, we have the doctrinal command to argue that the product failed its primary design promise.

The FDA’s 510(k) Pathway: A Regulatory Shortcut

Many women in New Hampshire ask, “How was this allowed in the operating room if it wasn’t safe?” The answer lies in the FDA’s 510(k) clearance pathway. Unlike a full Premarket Approval (PMA) process, which requires rigorous clinical trials, the 510(k) pathway only requires a manufacturer to show that their device is “substantially equivalent” to an older device (a “predicate”).

This has led to what we call “predicate creep.” For example, the GalaFLEX mesh used the 510(k) pathway by claiming it was equivalent to a surgical suture. A suture is not a breast-supporting scaffold, yet the FDA permitted this comparison. Because these devices are cleared through 510(k), they do not enjoy the same “preemption” protection as PMA-approved devices. This means that under the precedent of Medtronic v. Lohr, we can file state-law negligence and design-defect claims in New Hampshire without them being automatically dismissed by federal law.

Ralph Manginello’s twenty-seven years of practice and admission to the United States District Court for the Southern District of Texas provide the firm with the ability to navigate these complex federal jurisdictional issues. While your case may be filed in the U.S. District Court for the District of New Hampshire in Concord, the litigation often coordinates with multidistrict litigation (MDL) pipelines, such as MDL 2921 (Allergan BIOCELL), where a bellwether trial is currently scheduled for October 19, 2026.

Legal Advocacy Rooted in New Hampshire Law

At Attorney911, we recognize that New Hampshire’s legal framework has its own nuances. If you were injured by a defective medical device in the Granite State, your case is governed by specific rules:

• Statute of Limitations: New Hampshire generally provides a three-year window from the date you discovered (or reasonably should have discovered) your injury and its connection to the device. However, the “discovery rule” is complex. If you had reconstruction in 2018 but only received the FDA’s “Warning to Health Care Providers” in November 2023, your clock might have only recently started.
• Discovery Rule and Latent Injury: Because BIA-ALCL can take 7 to 10 years to develop, and BIA-SCC can take up to 40 years, the discovery rule is the lifeline for many New Hampshire plaintiffs. We specialize in proving exactly when the link was established to preserve your right to sue.
• Modified Comparative Fault: New Hampshire follows a 51% rule. If you are found more than 50% responsible for your injury, you cannot recover. In medical device cases, the “fault” almost never lies with the patient, but the defense will try to blame “lifestyle factors” or “surgical technique.” Our job is to shift the focus back to the defective design of the ADM or scaffold.
• Strict Liability: New Hampshire recognizes the doctrine of strict liability for defective products. We do not necessarily have to prove the manufacturer was “careless”—we have to prove the product was in a defective condition and unreasonably dangerous when it left their control.

Our firm’s experience is not just theoretical. Ralph Manginello is a member of the Pro Bono College of the State Bar of Texas, a recognition for those who exceed seventy-five hours of service annually, and our firm maintains a 4.9 out of 5.0-star rating across hundreds of reviews. We bring that same level of service and dedication to every woman we represent in New Hampshire.

Who We Are Fighting For: The Plaintiff Profiles

We represent a diverse group of women across New Hampshire, each facing a unique set of challenges:

1. The Breast Cancer Survivor: You beat cancer at a center like North Country Healthcare or Concord Hospital, only to have your reconstruction fail because of a defective acellular dermal matrix. The “financial toxicity” of these complications—averaging over $7,000 in additional costs in the first year alone—on top of the emotional toll is why we seek maximum compensation.
2. The BRCA1/BRCA2 Previvor: You chose a prophylactic mastectomy to protect your future, but a defective bioabsorbable scaffold has left you with permanent disfigurement or chronic pain. You feel like the “safety” you bought with surgery was a lie.
3. The Cosmetic Revision Patient: You wanted a lift or an augmentation in a Nashua or Portsmouth practice, and your surgeon used a “mesh bra” for support. Now, that mesh has eroded through your skin or caused a Baker Grade III/IV capsular contracture.
4. The Families of the Lost: Sadly, some complications lead to sepsis or advanced stage BIA-ALCL. We represent the families in New Hampshire who are seeking justice through wrongful death claims against the multi-billion dollar corporations that manufactured these risks.

The Cigna insurance decision in April 2025 to begin covering GalaFLEX for certain procedures further complicates the landscape, as it may lead to even higher volumes of these devices being used in New Hampshire. We are staying ahead of these trends to ensure our clients have the most current advocacy available.

Why Choose The Manginello Law Firm (Attorney911)?

When you are looking for an attorney to handle a medical device injury in New Hampshire, you have choices. Many “national” firms take thousands of cases and treat them like numbers. We take a different approach.

• Federal Court Command: Ralph Manginello is admitted to federal court and has been practicing since November 1998. We understand how to thread a state-law claim so that it survives federal preemption.
• The Insurance Defense Advantage: Associate Lupe Peña brings a background that includes understanding how insurance carriers value claims. We know the “Defense Playbook” before they even open their files.
• Bilingual Representation: We are committed to access. Lupe Peña conducts full consultations in Spanish, removing the barriers that often prevent New Hampshire’s diverse communities from seeking legal help.
• High-Profile Litigation Capability: Our current work in Bermudez v. Pi Kappa Phi demonstrates our ability to take on institutional defendants with massive resources. We are not intimidated by the billion-dollar quarterly revenues of Becton Dickinson or Allergan.
• No Upfront Cost: We work on a contingency fee basis. This means we take on all the financial risk. We pay for the expert pathologists, the regulatory consultants, and the court filings. You pay nothing unless we recover compensation for you.

We are local and civic-minded. Ralph Manginello is a member of the Pasadena Chamber of Commerce and was recently recognized by his alma mater, Cheshire Academy, in their Hall of Fame. We bring this culture of excellence and accountability to every New Hampshire case.

Frequently Asked Questions for New Hampshire Patients

Is surgical mesh actually approved by the FDA for breast surgery?
No. As of our latest review of the regulatory record, the FDA has not approved any surgical mesh, ADM, or scaffold specifically for use in breast reconstruction or augmentation. They are “cleared” for general soft-tissue reinforcement, and their use in the breast is “off-label.”

What if my surgeon recommended the mesh? Can I still sue the manufacturer?
Yes. Under the doctrine we follow, if the manufacturer marketed the device to surgeons for breast use without providing adequate warnings or clinical data, the manufacturer is the primary liable party. The “Learned Intermediary Doctrine” is often eroded when manufacturers engage in deceptive off-label promotion.

How do I find out what was used in my surgery?
You have a legal right to your medical records. You can request a “Complete Operative Report” from your surgical facility (e.g., Wentworth-Douglass or St. Joseph Hospital). We look specifically for the “Implant Log” or “Device Stickers” that contain the lot numbers and UDIs (Unique Device Identifiers).

Are these lawsuits part of a class action?
Most medical device injuries are handled as “Mass Torts” or coordinated through an MDL (Multidistrict Litigation). This is different from a class action. In an MDL, your specific injuries, your specific medical bills, and your specific pain and suffering determine your recovery. You are an individual, not part of a one-size-fits-all settlement.

What is the time limit to file a claim in New Hampshire?
While the general statute is three years, every case is different. Contacting us at 1-888-ATTY-911 as soon as you suspect an injury is the best way to ensure your rights are protected.

Can I sue for “Red Breast Syndrome”?
Yes. If we can show that the acellular dermal matrix (like FlexHD or AlloMax) had an elevated complication profile that was not properly disclosed, or if endotoxin contamination caused the reaction, you may have a viable product liability claim.

What if I already had the mesh removed?
The removal (explantation) is actually a critical piece of evidence. If you still have the explanted material, or if it is being held by a pathology lab at a facility like the Elliot, we can work to preserve it for testing. Even if it was discarded, your pathology reports and operative notes provide the necessary evidence.

Does it cost anything to talk to you?
Never. We offer free, confidential consultations to any woman in New Hampshire who has been affected by these devices.

Direct Guidance: Your Next Steps in New Hampshire

If you are suffering, we encourage you to take these steps immediately:

1. Prioritize Your Health: If you have signs of infection (fever, warmth, redness), seek medical care at the nearest New Hampshire emergency department immediately.
2. Request Your Documentation: Use your patient portal or call the medical records department at your surgeon’s office. Ask specifically for the “Operative Note” and the “Implant Stickers.”
3. Document Your Journey: Keep a journal of your symptoms. Take date-stamped photographs of any visible swelling, redness, or deformity.
4. Preserve Evidence: If you are scheduled for a revision surgery, tell your surgeon you wish to preserve any removed mesh or tissue for legal review.
5. Speak with Counsel: Call us at 1-888-ATTY-911. We can handle the heavy lifting of the investigation while you focus on your recovery.

We serve families across the Granite State, from the White Mountains to the Monadnock region and everywhere in between. Whether your surgery was in a major hospital or a private clinic in Bedford or Stratham, our firm provides the technical expertise that generalist personal injury firms simply cannot match.

Conclusion: You Deserve Compassionate, Aggressive Advocacy

The corporations that manufactured these products—companies like Becton Dickinson with annual revenues exceeding $20 billion—have legal teams dedicated to denying your claim. They will argue that your body’s reaction was “unpredictable” or that the surgeon chose the off-label use. We know better. We know that these products were pushed into New Hampshire operating rooms with incomplete data and minimized risks.

At The Manginello Law Firm, PLLC, we believe that every woman who has survived a mastectomy or sought to reclaim her confidence through surgery deserves a safe outcome. When that outcome is stolen by a defective device, we fight for the compensation you need to pay for revision surgeries, lost wages, and the pain you have endured.

Ralph Manginello’s twenty-seven years of continuous practice and Lupe Peña’s bilingual, insurance-savvy approach make Attorney911 the obvious choice for your representation. We invite you to join the many clients who have given us a 4.9-star rating and call 1-888-ATTY-911 today.

Hablamos español. Estamos aquí para ayudarla a buscar la justicia que merece. No hay cargos a menos que recuperemos una compensación para usted.

When you are ready to talk, we are here to listen. Your story matters, your health matters, and your future in New Hampshire depends on having the right team by your side. Contact us today for your free, confidential consultation.

Disclaimer: This guide is for educational purposes and does not constitute medical or legal advice. Past results do not guarantee future outcomes. The Manginello Law Firm, PLLC is a Texas-based firm with federal court admissions; we work with local counsel in other jurisdictions to ensure your case is handled in compliance with New Hampshire professional standards. No attorney-client relationship is formed until a written contract is signed.